Indication

Haemophilus influenzae type b vaccination

Haemophilus influenzae type b vaccination is an active immunization procedure indicated for the prevention of invasive disease caused by the encapsulated bacterium *Haemophilus influenzae* serotype b. Read more about Haemophilus influenzae type b vaccination

15 drugs 5 manufacturers

Advertisement

Drugs that treat it

Common Haemophilus influenzae type b vaccination therapies.

Showing 10–15 of 15 drugs

Filter & compare in the drug finder →Opens the drug finder with Haemophilus influenzae type b vaccination preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Haemophilus influenzae type b vaccination.

Haemophilus influenzae type b vaccination is an active immunization procedure indicated for the prevention of invasive disease caused by the encapsulated bacterium *Haemophilus influenzae* serotype b.

The target organism primarily threatens infants and children younger than five years of age, as well as individuals with anatomic or functional asplenia and other immunocompromising conditions.

In unimmunized populations, the pathogen colonizes the nasopharynx and can breach mucosal barriers to enter the bloodstream, resulting in severe, life-threatening systemic manifestations including purulent meningitis, epiglottitis, bacteremic pneumonia, septic arthritis, and fulminant septicemia.

Personalize your experience

Follow Haemophilus influenzae type b vaccination and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it